Key Points
-
This guideline describes the administration of nebulised medications used in respiratory diseases such as Cystic Fibrosis and bronchiectasis.
-
Included in the table are recommended doses, cautions, appropriate nebuliser devices and potential side effects.
-
Medications are listed alphabetically by generic drug name, but prescribing should be brand specific due to the specific administration instructions for each formulation.
| Version: | 3 |
|---|---|
| Date Issued: | 14 June 2024 |
| Review Date: | July 2026 |
| Key words: | Nebules, nebulised, nebuliser, cystic fibrosis, bronchiectasis, pharmacy, physiotherapy, medication. |
This is a controlled document. If you are using a printed copy, check it against the guidelines site to ensure you are using the latest edition. Print copies must be destroyed after use.